Germany is not going to legalize cannabis this month. German lawmakers have decided to postpone the vote on cannabis legalization, which was originally scheduled to take place next week, before December 2023. The originally planned entry into force of the cannabis law on January 1st, 2024, will not happen. Experts predict that the bill will go into effect in March 2024.
Social Democratic Party (SPD) MP Carmen Wegge announced the delay, stressing the need for further work on the bill.
Read more about the postponing of cannabis legalization in Germany and find other important cannabis news from around the world with the Hemp.im mobile app, available for free for both Android and iOS devices.
This means that Germany will have to wait longer to legalize cannabis
“The decision on CannG will be made in December. This means that we are falling behind schedule. I know this is a huge disappointment for many. Therefore, this decision was not easy for anyone. However, well-designed improvements are in everyone’s interest.”
Kirsten Kappert-Gonther of the Green Party explained the delay as an opportunity to improve the bill. It is an attempt to ensure that the reform is implemented in a responsible and quality-focused manner.
The Bundesrat, the body representing the German states, will also have to adjust its actions to accommodate the delay in the Bundestag. This could affect the legislative timetable.
Despite the delay, some observers believe the reform may be introduced later than originally planned. This is generating mixed reactions in the public, with some feeling disappointment over the protracted process.
The bill calls for the legal possession of up to 25g of cannabis for personal use and the cultivation of up to 3 cannabis plants by adults, the creation of cannabis clubs, and a pilot program for commercial sales. It’s a comprehensive reform that will have a broad impact on national and European drug policy.
Coalition government leaders stress the need to educate the public about the dangers of cannabis use. They want to ensure that the legalization process in Germany will be accompanied by an educational campaign.
However, the process of legalizing cannabis in Germany has been met with resistance from many institutions, including doctors, judges, police, and medical organizations. This shows that the reform has its supporters, but also opponents.
There are also plans for commercial sales programs in cities across the country, which will be revealed once the idea is approved by the European Commission. This is the next step in the reform, which will affect the cannabis market in Germany.
Ultimately, the delay in the process of legalizing cannabis in Germany raises many questions about the future of drug policy and may affect when and how legalization will be implemented. This is a topic that will continue to be followed by the public and political observers.
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in FaktyKonopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
ESG Investing Is About Getting It Right Over the Long Term Without Losing Profitability
There are many aspects that condition the selection criteria in ESG investment, such as the environmental or social dimensions, without...
Soybeans and Soybean Oil Appears to start a New Leg Down on the Charts
Soybeans and the products closed lower last week on improved rains for central and northern Brazil and still too much...
Why Coinbase Increasingly Relies on Solana
The crypto exchange Coinbase has set itself the goal of processing transactions in less than a second and for less...
Roche Will Pay Up to €2.8 Billion for Carmot Therapeutics
Roche is set to acquire Carmot Therapeutics, along with three clinical-stage assets for treating obesity and diabetes, for a maximum...
Groupon Is Overhyped and Overexposed — Here’s Why RDE, Inc. Is a Better Alternative
In the last month or so, Groupon’s been on a little bit of a recovery bull run following some hype...
Cannabis2 weeks ago
The Illegal Cannabis Market in Europe Reaches €11.4 Billion
Impact Investing5 days ago
Why the Carbon Credit Market Is Not Working
Biotech2 weeks ago
Why Bayer Sinks a Staggering 21.3% on the Frankfurt Stock Exchange
Cannabis1 week ago
Germany Plans to Legalize Home Cultivation and Possession of Cannabis as of April 1st, 2024